文献速递分子诊断质量管理与危急值

药物基因组学检测中的确认实践:多好才算足够好?

Confirmation practice in pharmacogenetic testing; how good is good enough?
PubMed 文献 · Clin Chim Acta · 2018-12-21

药物基因组学检测日益进入常规诊断,但确认实践(如采用两种独立基因分型技术)缺乏明确指南。本文以DPYD基因分型为例,通过调查揭示实验室确认实践存在显著异质性(54%的实验室采用不同形式的确认实践),并评估两家大型基因分型机构超过10年的结果,发现9例患者(0.01%)存在可能源于等位基因脱扣的检测差异。作者认为对高临床影响的基因检测(如DPYD检测)采用第二种独立技术是有用的,指南有助于统一药物基因组学确认实验室实践,并可能需要按基因和检测项目具体规定。

要点

  • 药物基因组学检测的确认实践缺乏明确指南,实验室间存在显著异质性。
  • 调查显示54%的实验室采用不同形式的确认实践。
  • 两家大型机构超过10年基因分型结果中仅9例患者(0.01%)出现检测差异,可能源于等位基因脱扣。

核心结论

  • 对高临床影响的基因检测(如DPYD检测)采用第二种独立技术是有用的。
  • 指南有助于统一药物基因组学确认实验室实践,并可能需要按基因和检测项目具体规定。

研究设计与样本

  • 通过调查探索实验室当前的确认实践。
  • 评估两家大型基因分型机构超过10年的基因分型结果,两家机构均使用第二种独立基因分型技术。

主要发现

  • 调查观察到显著异质性,54%的实验室采用不同形式的确认实践。
  • 两家机构超过10年结果中,9例患者(0.01%)存在检测差异,可能源于等位基因脱扣。

关键数值与推荐

  • 54%的实验室采用不同形式的确认实践。
  • 检测差异在9例患者(0.01%)中被识别,可能源于等位基因脱扣。

临床怎么用

  • 对高临床影响的基因检测(如DPYD检测)可考虑采用第二种独立技术进行确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacogenetic testing is increasingly implemented in routine diagnostics. However, quality control measures, in particular confirmation practices e.g. the use of two independent genotyping techniques, are subject of debate and there are no clear guidelines. The aim of the current paper is to discuss the current practice in confirmation testing in the field of pharmacogenetics and draw attention to this situation. DPYD genotyping is used as a case example to highlight the importance of assigning the correct genotype. Current confirmation practices in laboratories are explored through a survey. Substantial heterogeneity was observed with 54% of the laboratories applying different forms of confirmation practice. Finally, we evaluated over 10 years of genotyping results from two large genotyping facilities, which both use a second, independent genotyping technique. Discrepancies between tests were identified in 9 patients (0.01%), possibly due to allele dropout. We feel that a second, independent technique is useful for genetic tests with a high clinical impact, such as DPYD testing. Guidelines can help to align confirmatory laboratory practices for pharmacogenetics, which may need to be specified per gene and test.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Lunenburg CATC, Guchelaar HJ, van Schaik RHN, et al. Confirmation practice in pharmacogenetic testing; how good is good enough? Clin Chim Acta. 2018. PMID: 30582901. doi:10.1016/j.cca.2018.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。